Literature DB >> 11406726

Aspirin in patients with coronary artery disease: is it simply irresistible?

G V Nair1, C J Davis, M E McKenzie, D R Lowry, V L Serebruany.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11406726     DOI： 10.1023/a:1011220615447

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  112 in total

1.  Aggrenox: a combination of antiplatelet drugs for stroke prevention.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2000-02-07       Impact factor: 1.909

2.  Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries.

Authors:  N Maalej; J D Folts
Journal:  Circulation       Date:  1996-03-15       Impact factor: 29.690

3.  Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II.

Authors: 
Journal:  Lancet       Date:  1997-05-17       Impact factor: 79.321

4.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

5.  Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.

Authors:  P Patrignani; P Filabozzi; C Patrono
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

6.  Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits.

Authors:  M R Buchanan; J Hirsh
Journal:  Arteriosclerosis       Date:  1984 Jul-Aug

7.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

Review 8.  The biochemical pharmacology of thromboxane synthase inhibition in man.

Authors:  G A FitzGerald; I A Reilly; A K Pedersen
Journal:  Circulation       Date:  1985-12       Impact factor: 29.690

9.  Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.

Authors:  J L Moake; N A Turner; N A Stathopoulos; L Nolasco; J D Hellums
Journal:  Blood       Date:  1988-05       Impact factor: 22.113

10.  Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.

Authors:  A J Marcus; B B Weksler; E A Jaffe; M J Broekman
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808
View more
  1 in total

1.  Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease.

Authors:  A R Muir; M F McMullin; C Patterson; P P McKeown
Journal:  Heart       Date:  2008-08-12       Impact factor: 5.994
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.